BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 22288900)

  • 1. Bacterial infections in cirrhosis: role of proton pump inhibitors and intestinal permeability.
    van Vlerken LG; Huisman EJ; van Hoek B; Renooij W; de Rooij FW; Siersema PD; van Erpecum KJ
    Eur J Clin Invest; 2012 Jul; 42(7):760-7. PubMed ID: 22288900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis.
    Bauer TM; Steinbrückner B; Brinkmann FE; Ditzen AK; Schwacha H; Aponte JJ; Pelz K; Kist M; Blum HE
    Am J Gastroenterol; 2001 Oct; 96(10):2962-7. PubMed ID: 11693333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.
    Bajaj JS; Zadvornova Y; Heuman DM; Hafeezullah M; Hoffmann RG; Sanyal AJ; Saeian K
    Am J Gastroenterol; 2009 May; 104(5):1130-4. PubMed ID: 19337238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chronic use of beta-blockers and proton pump inhibitors may affect the rate of bacterial infections in cirrhosis.
    Merli M; Lucidi C; Di Gregorio V; Giannelli V; Giusto M; Ceccarelli G; Riggio O; Venditti M
    Liver Int; 2015 Feb; 35(2):362-9. PubMed ID: 24836902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between acid suppressive therapy and spontaneous bacterial peritonitis in cirrhotic patients with ascites.
    Choi EJ; Lee HJ; Kim KO; Lee SH; Eun JR; Jang BI; Kim TN
    Scand J Gastroenterol; 2011 May; 46(5):616-20. PubMed ID: 21275825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of proton pump inhibitors in the occurrence and the prognosis of spontaneous bacterial peritonitis in cirrhotic patients with ascites.
    de Vos M; De Vroey B; Garcia BG; Roy C; Kidd F; Henrion J; Deltenre P
    Liver Int; 2013 Oct; 33(9):1316-23. PubMed ID: 23730823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acid-suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis.
    Deshpande A; Pasupuleti V; Thota P; Pant C; Mapara S; Hassan S; Rolston DD; Sferra TJ; Hernandez AV
    J Gastroenterol Hepatol; 2013 Feb; 28(2):235-42. PubMed ID: 23190338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression.
    Goel GA; Deshpande A; Lopez R; Hall GS; van Duin D; Carey WD
    Clin Gastroenterol Hepatol; 2012 Apr; 10(4):422-7. PubMed ID: 22155557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitor use significantly increases the risk of spontaneous bacterial peritonitis in 1965 patients with cirrhosis and ascites: a propensity score matched cohort study.
    Min YW; Lim KS; Min BH; Gwak GY; Paik YH; Choi MS; Lee JH; Kim JJ; Koh KC; Paik SW; Yoo BC; Rhee PL
    Aliment Pharmacol Ther; 2014 Sep; 40(6):695-704. PubMed ID: 25078671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitors do not increase the risk for recurrent spontaneous bacterial peritonitis in patients with cirrhosis.
    Kim JH; Lim KS; Min YW; Lee H; Min BH; Rhee PL; Kim JJ; Koh KC; Paik SW
    J Gastroenterol Hepatol; 2017 May; 32(5):1064-1070. PubMed ID: 28449345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: a multicenter prospective study.
    Terg R; Casciato P; Garbe C; Cartier M; Stieben T; Mendizabal M; Niveyro C; Benavides J; Marino M; Colombato L; Berbara D; Silva M; Salgado P; Barreyro F; Fassio E; Gadano A;
    J Hepatol; 2015 May; 62(5):1056-60. PubMed ID: 25481567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
    Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
    Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality associated with proton pump inhibitors in cirrhotic patients with spontaneous bacterial peritonitis.
    Kwon JH; Koh SJ; Kim W; Jung YJ; Kim JW; Kim BG; Lee KL; Im JP; Kim YJ; Kim JS; Yoon JH; Lee HS; Jung HC
    J Gastroenterol Hepatol; 2014 Apr; 29(4):775-81. PubMed ID: 24219827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia.
    de Jager CP; Wever PC; Gemen EF; van Oijen MG; van Gageldonk-Lafeber AB; Siersema PD; Kusters GC; Laheij RJ
    Aliment Pharmacol Ther; 2012 Nov; 36(10):941-9. PubMed ID: 23034135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis.
    Wallace JL; Syer S; Denou E; de Palma G; Vong L; McKnight W; Jury J; Bolla M; Bercik P; Collins SM; Verdu E; Ongini E
    Gastroenterology; 2011 Oct; 141(4):1314-22, 1322.e1-5. PubMed ID: 21745447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites.
    Dam G; Vilstrup H; Watson H; Jepsen P
    Hepatology; 2016 Oct; 64(4):1265-72. PubMed ID: 27474889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PROTON PUMP INHIBITORS INCREASE THE OVERALL RISK OF DEVELOPING BACTERIAL INFECTIONS IN PATIENTS WITH CIRRHOSIS.
    Lázaro-Pacheco IB; Servín-Caamaño AI; Pérez-Hernández JL; Rojas-Loureiro G; Servín-Abad L; Tijera FH
    Arq Gastroenterol; 2018; 55(1):28-32. PubMed ID: 29561973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis.
    Chang CS; Chen GH; Lien HC; Yeh HZ
    Hepatology; 1998 Nov; 28(5):1187-90. PubMed ID: 9794900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation.
    Schmidt M; Johansen MB; Robertson DJ; Maeng M; Kaltoft A; Jensen LO; Tilsted HH; Bøtker HE; Sørensen HT; Baron JA
    Aliment Pharmacol Ther; 2012 Jan; 35(1):165-74. PubMed ID: 22050009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between proton pump inhibitor use and spontaneous bacterial peritonitis in cirrhotic patients with ascites.
    Ratelle M; Perreault S; Villeneuve JP; Tremblay L
    Can J Gastroenterol Hepatol; 2014 Jun; 28(6):330-4. PubMed ID: 24945188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.